News

Nightingale – a Finnish company on a mission to solve the global chronic disease crisis

6.8.2019

According to the World Health Organization, at least 80 % of all heart disease, stroke ...

Pharmaceutical injuries insurance

27.6.2019

In Finland there is a voluntary compensation system to protect medicine users: pharmaceutical injuries insurance. ...

HIMSS & Health 2.0 European Conference

25.6.2019
HIMSS & Health 2.0 European conference took place on 11-13.6.2019 in Helsinki. 3 000 professionals ...

Suomalainen tutkimuskenttä muuttuu – useita lakiuudistuksia tulossa

17.6.2019

Miten suomalainen tutkimuskenttä muuttuu lakiuudistusten myötä? Sirpa Soinin (varatuomari, THL Biopankin johtaja) erikoisalaa ovat kansanterveyteen, ...

Nightingale – a Finnish company on a mission to solve the global chronic disease crisis

6.8.2019

According to the World Health Organization, at least 80 % of all heart disease, stroke ...

Pharmaceutical injuries insurance

27.6.2019

In Finland there is a voluntary compensation system to protect medicine users: pharmaceutical injuries insurance. ...

HIMSS & Health 2.0 European Conference

25.6.2019
HIMSS & Health 2.0 European conference took place on 11-13.6.2019 in Helsinki. 3 000 professionals ...

Suomalainen tutkimuskenttä muuttuu – useita lakiuudistuksia tulossa

17.6.2019

Miten suomalainen tutkimuskenttä muuttuu lakiuudistusten myötä? Sirpa Soinin (varatuomari, THL Biopankin johtaja) erikoisalaa ovat kansanterveyteen, ...

Medaffcon on Twitter

06.08.2019 5:59
How could chronic diseases be prevented? Medaffcon met with Nightingale Health, a #Finnish company on a mission to solve the global #chronicDisease crisis. Read our newest Future Care Finland article. #biotech https://t.co/2wYMlDv3UL
01.08.2019 5:42
How does the #Finnish #pharmaceutical injuries insurance work? Tiina Hellgrén, LLM, CEO of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities, explains this in the recently published Future Care Finland article https://t.co/gzqLKEtBPt
04.07.2019 7:17
A new real-world #study published: This real-world study demonstrates that adult #asthma represents a significant #disease burden in #Finland, with an increased burden in patients with severe and/or eosinophilic disease. Read the whole study https://t.co/sJCtE9iB4p

Medaffcon on Youtube

Medaffcon’s news archive

News Archive »

At Medaffcon, we are devoted to providing means for data-driven decision-making in healthcare and working towards economically sustainable, effective and more individualized treatment care. We believe that Finland is at the forefront of developing tomorrow’s healthcare and mapping the treatment paths of the future. Future Care Finland, a platform that highlights Finnish innovations, technologies and applications that aim to facilitate customized patient care, was born from the desire to share these visions with all people interested in future healthcare and wellbeing. Read more!

Read more »